India, July 27 -- Today's top biotech gainers include Entera Bio, following an oversubscribed private placement financing; Gossamer, which is progressing toward a planned Seralutinib NDA submission in September; First Tracks, which has been firing on all cylinders since its Nasdaq debut; and Forte Biosciences, following its agreement to be acquired by argenx, among others.
Read on.
ENTX Soars on Oversubscribed Financing
Entera Bio Ltd. (ENTX), a clinical-stage company, led the pack of gainers on Monday, with shares soaring more than 90%.
The company announced that it has entered into a securities purchase agreement for an oversubscribed private placement financing, expected to generate approximately $275 million in gross proceeds. The P...